Northern Trust’s Sinovac Biotech, Ltd SVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,787
| Closed | – | – | 4642 |
|
|
2023
Q3 | $0 | Hold |
13,787
| – | – | ﹤0.01% | 4619 |
|
|
2023
Q2 | $0 | Buy |
+13,787
| New | – | ﹤0.01% | 4682 |
|
|
2022
Q4 | – | Sell |
-13,787
| Closed | -$55K | – | 4798 |
|
|
2022
Q3 | $55K | Hold |
13,787
| – | – | ﹤0.01% | 4303 |
|
|
2022
Q2 | $55K | Buy |
+13,787
| New | +$55K | ﹤0.01% | 4380 |
|
|
2022
Q1 | – | Sell |
-13,787
| Closed | -$55K | – | 4886 |
|
|
2021
Q4 | $55K | Hold |
13,787
| – | – | ﹤0.01% | 4581 |
|
|
2021
Q3 | $55K | Hold |
13,787
| – | – | ﹤0.01% | 4524 |
|
|
2021
Q2 | $55K | Hold |
13,787
| – | – | ﹤0.01% | 4481 |
|
|
2021
Q1 | $55K | Sell |
13,787
-8,587
| -38% | -$34.3K | ﹤0.01% | 4375 |
|
|
2020
Q4 | $55K | Hold |
22,374
| – | – | ﹤0.01% | 4226 |
|
|
2020
Q3 | $55K | Hold |
22,374
| – | – | ﹤0.01% | 4097 |
|
|
2020
Q2 | $55K | Hold |
22,374
| – | – | ﹤0.01% | 4046 |
|
|
2020
Q1 | $55K | Hold |
22,374
| – | – | ﹤0.01% | 3939 |
|
|
2019
Q4 | $55K | Hold |
22,374
| – | – | ﹤0.01% | 4046 |
|
|
2019
Q3 | $55K | Hold |
22,374
| – | – | ﹤0.01% | 4041 |
|
|
2019
Q2 | $55K | Hold |
22,374
| – | – | ﹤0.01% | 4070 |
|
|
2019
Q1 | $144K | Hold |
22,374
| – | – | ﹤0.01% | 3839 |
|
|
2018
Q4 | $155K | Hold |
22,374
| – | – | ﹤0.01% | 3844 |
|
|
2018
Q3 | $170K | Buy |
+22,374
| New | +$161K | ﹤0.01% | 3902 |
|
Other funds holding SVA
O
NAH
TFA
HI
Northern Trust's SVA Position: Q4 2023 in Review
Northern Trust sold out of Sinovac Biotech, Ltd (SVA) in Q4 2023, closing a stake of 13,787 shares.
Northern Trust first reported a position in SVA in Q3 2018 and held it in 18 quarters. The position peaked at $170K in Q3 2018. 8 funds tracked by Wall St. Rank hold SVA as of Q4 2023.
- Northern Trust reported no remaining Sinovac Biotech, Ltd position as of Q4 2023 after selling out during the quarter.
- Northern Trust sold 13,787 Sinovac Biotech, Ltd shares in Q4 2023.
- Northern Trust first reported a position in Sinovac Biotech, Ltd in Q3 2018 and held it in 18 quarters.
- Northern Trust's Sinovac Biotech, Ltd position peaked at $170K in Q3 2018.
- 8 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q4 2023.
Based on Northern Trust's 13F filing for Q4 2023, filed 13 Feb 2024.